The resonance Raman (RR) spectrum of C60 has been
studied in benzene and carbon disulfide using eight
excitation wavelengths between 406.7 and 647.1 nm. Raman
excitation profile calculations have been
performed on the five most intense RR bands; the
Hg(1), Ag(1), Gg(4),
Hg(7), and Ag(2) vibrational
modes.
Two main scattering mechanisms predominate, Herzberg−Teller (HT)
B-term scattering and nonadiabatic
D-term scattering. This is the first observation of rare D-term
scattering in a system without a metal. The
requirement of a Jahn−Teller distortion of the excited state,
produced upon population of the degenerate T1u
LUMO, is essentially negated by solvent distortion of the symmetry of
C60. While the I
h
point group is a
good descriptor for the 10 fundamental Raman modes of C60,
the slight reduction in the high symmetry of the
molecule, due to solvent and 13C effects, activates at
least 6 of the remaining 36 Raman-silent modes. At
resonance with the HOMO−LUMO transition of C60, or its
vibronic sideband, the solution resonance Raman
spectra of C60 display almost the full gamut of RR
scattering phenomena with no fewer than 13 distinct
classes of first- and second-order vibrational features. The
intensity behavior and the depolarization ratio of
the band due to the I
h
-Raman-silent
Gg(4) mode at 1140 cm-1
suggest that the distorted excited state is best
approximated as having
D
5
d
symmetry. The
presence of overtones and combinations of Raman-active and
Raman-silent vibrational modes is explained in terms of a second-order
HT scattering. These studies of the
RR spectroscopy of C60 in solution have implications for
the electron-pairing mechanism in the superconductivity of fullerides and the nature of solute−solvent associations such
as between water-soluble derivatives of
C60 and HIV-1 protease.
The resonance Raman (RR) spectrum of C70 has
been studied in benzene using 11 laser excitation energies
across the main visible absorption band (MVAB) of C70
between 514.5 and 406.7 nm. Raman excitation profiles
(REPs) were constructed for the 15 most intense RR bands of
C70, and symmetry assignments have been made
partly on the basis of polarization work. Contrast is made to work
performed on thin films where problems have
arisen from the symmetry-lowering effect of the surface and from
neglect of resonance. Assignments for nine other
less intense RR bands are suggested. Three electronic transitions
under the MVAB are identified and assigned
definitively: the HOMO − 4 (e2‘‘) → LUMO + 1
(e1‘‘) transition in the 514/501-nm excitation region, the
HOMO
− 5 (e1‘) → LUMO + 1 (e1‘‘) transition in
the 476/472-nm excitation region, and the HOMO (a2‘‘) →
LUMO + 2
(a1‘‘) in the 457/452-nm excitation region. The REPs
reveal that these three electronic transitions are
vibronically
coupled to the strong electronic transition at 382 nm which is assigned
to the HOMO − 2 (a2‘) → LUMO + 3
(e1‘)
transition. RR B-term scattering mechanisms are the
major source of intensity enhancement for bands of the
totally-symmetric A1‘ and the non-totally-symmetric E1‘‘
and E2‘ Raman modes. The REPs of the 15 bands are
grouped
into four types that provide insight into the change in the electronic
distribution upon excitation for each transition.
Unlike C60, whose extraordinarily high symmetry makes
it very sensitive to solvent-induced symmetry lowering and
whose RR spectrum is rich in forbidden, overtone, and combination
bands, C70 displays a restricted subset of RR
scattering phenomena. The lower symmetry and more localized
molecular orbitals of C70 make it a better model
for
the RR scattering mechanisms and vibronic coupling expected in the
higher fullerenes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.